Form D · Biotechnology
TRex Holdings Inc.
South San Francisco, CA · CIK 0002046270
Offering snapshot reported Nov 26, 2024 · SEC filing
- Reported sold
- $42.3M Offering amount: $85M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 7, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 26, 2024 | Initial | $42,279,369 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-530561
Source: Form D, filed Nov 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Baran | Director |
| Alexandra Cantley | Director |
| Travis Coy | Director |
| M. Johnston Erwin Jr. | Director, Executive |
| Carol Gallagher | Director |
| Peter Hirth | Director |
| Eric Huang | Director |
| Joel Marcus | Director |
| Sanjay Mistry | Director |
| Eric Pham | Director |
| Michael Ross | Director |
| Nikola Trbovic | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
681 Gateway Blvd., 4 Th Floor
South San Francisco, CA, 94080
South San Francisco, CA, 94080